We are delivering systemic autologous stem cells and stromal fractional gradient (the juice around these cells) to these patients in hopes that these cells can aid in the regeneration and rejuvenation of the heart muscle. Doing so would allow them to have stronger pumping of their blood and hopefully fewer symptoms.
As with all of our protocols, our patients will be enrolled in our investigational study to help determine the effectiveness of this still experimental treatment modality.